Innovators Welcome UK Plans To Expand Investor Pool For Life Science Products
Uptick In Life Science Investor Confidence Points To Improving Outlook
While medtechs still find the investment environment difficult, good companies will continue to get funded. So says Taylor Wessing partner Ross McNaughton, adding that UK life sciences innovators should in the longer-term benefit from more funds going into VC and PE under The Mansion House Compact.
